Previous cell-based in vitro approaches have indeed demonstrated that low percentage abundances of certain LQTS- or CPVT-linked CALM mutants relative to those of wild-type CALM proteins were able to induce distinct phenotypes, suggesting a potent dominant-negative effect of mutant CALM molecules on their target proteins (5, 6). The gene discussed is CALM3; the disease is familial long QT syndrome.